Lactobacillus crispatus KBL693 alleviates atopic dermatitis symptoms through immune modulation.
- 2025-10-31
- Journal of microbiology (Seoul, Korea) 63(10)
- Seokcheon Song
- Jun-Hyeong Kim
- Sung Jae Jang
- Eun Jung Jo
- Sang Kyun Lim
- GwangPyo Ko
- PubMed: 41164963
- DOI: 10.71150/jm.2509005
- Low evidence
oral administration of KBL693 alleviated disease symptoms and reduced hallmark type 2 immune markers, including plasma IgE as well as IL-4, IL-5, and IL-13 levels in skin lesions
- Effect
- Beneficial
- Effect size
- Moderate